COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics-Reference-Cited by-同舟云学术

COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics

Published:2020-03-18 Issue:6 Volume:16 Page:1232-1238
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Dhama Kuldeep¹^ORCID,Sharun Khan²^ORCID,Tiwari Ruchi³^ORCID,Dadar Maryam⁴,Malik Yashpal Singh⁵^ORCID,Singh Karam Pal¹,Chaicumpa Wanpen⁶

Affiliation:

1. Division of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India

2. Division of Surgery, ICAR-Indian Veterinary Research Institute, Bareilly, India

3. Department of Veterinary Microbiology and Immunology, College of Veterinary Sciences, Deen Dayal Upadhayay Pashu Chikitsa Vigyan Vishwavidyalay Evum Go-Anusandhan Sansthan (DUVASU), Mathura, India

4. Razi Vaccine and Serum Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran

5. Division of Biological Standardization, ICAR-Indian Veterinary Research Institute, Bareilly, India

6. Center of Research Excellence on Therapeutic Proteins and Antibody Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

Funder

stated

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2020.1735227

Reference77 articles.

1. Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group

2. Drug treatment options for the 2019-new coronavirus (2019-nCoV)

3. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV